In addition, much effort has been made to develop targeted therapies targeting AKT signaling in breast cancer (Barnett et al. 2005; Hernandez-Aya and Gonzalez-Angulo 2011; Araki and Miyoshi 2018). The gene discussed is AKT1; the disease is breast cancer.